Aims: To determine whether the expression of proliferating cell nuclear antigen (PCNA) in villous cytotrophoblast could distinguish between placental tissue from a hydropic abortion and that from a partial hydatidiform mole. Methods: Tissue from 18 partial hydatidiform moles, 15 hydropic abortions, five normal first trimester placentas and five normal full term placentas were immunostained for expression of PCNA, using the monoclonal antibody PC10. 
In the routine histological examination of placental tissue from abortions it can be very difficult to distinguish between a hydropic abortion and a partial hydatidiform mole, a problem which is largely responsible for the very In partial hydatidiform moles the percentage of villous cytotrophoblastic cells staining positively for PCNA was, on average, lower than that in placentas from hydropic abortions. This indicates that undue trophoblastic proliferation-hyperplasia-is not a feature of partial hydatidiform moles and indeed any critical review of the histology of partial moles would confirm that this is so in most, though admittedly not all, partial moles. Most partial moles show, in fact, very little trophoblastic proliferation and in most the degree of such proliferation is lower than in normal first trimester placentas. It is the pattern, rather than the degree of trophoblastic proliferation, which is abnormal in partial moles, the villous trophoblast showing focal, multifocal, or circumferential proliferation rather than the polar or lateral proliferation seen in the normal placenta.
It could be argued, when considering these results, that fetal death occurs earlier in pregnancy in hydropic abortions than in partial hydatidiform moles and that therefore these two groups are not strictly comparable. This may be true but further supports our view that trophoblastic proliferation is not a feature of partial moles. If fetal death had occurred at a later stage of gestation in a non-molar abortion, the proliferative activity in the trophoblast in the abortion material would probably have been higher and would further exceed that seen in partial moles. It could further be argued that sampling error may have led to the missing of foci of trophoblastic hyperplasia in the partial hydatidiform moles. There is no reason to believe, however, that the sampling error in placental tissue from partial moles was any greater than in that from surgically terminated pregnancies or from hydropic abortions. Furthermore, if trophoblastic hyperplasia was so focal in partial moles that its presence could be missed as a result of sampling error in all the cases examined it could hardly be argued that hyperplasia of the trophoblast is a defining feature of a mole. Therefore, neither of these arguments detract from the finding that the degree of trophoblastic proliferation in partial hydatidiform moles is less than is that in both normal first trimester placentas and in placental tissue from hydropic abortions.
Staining of villous cytotrophoblastic cells for PCNA indicates clearly that trophoblastic hyperplasia is not, despite statements to the contrary, a feature of partial hydatidiform moles. Thus any attempt to distinguish between placentas from hydropic abortions and partial moles which is based on the supposed differences in trophoblastic proliferative activity between these two conditions will, as in this study, be doomed to failure.
